Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Novartis AG (NVS) vs SAP SE (SAP) Price & Performance

Novartis AGTrade
SAP SETrade

Price performance (Past 24H)

Key statistics

Novartis AG vs SAP SE — how do they compare? Novartis AG trades at $153.88 (market cap $290.25B), while SAP SE trades at $154.29 (market cap $183.83B). The key difference: Novartis AG is the larger of the two by market cap, and Novartis AG pays the higher dividend (3.17%). Which is the better fit depends on your goals.

NVSSAP
Market Cap
$290.25B$183.83B
Sector
HealthTechnology
52-Week High
$168.62$307.27
52-Week Low
$113.50$148.06
Enterprise Value
$330.27B$181.35B
Dividend Yield
3.17%1.85%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Novartis AG

Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.

Read more on NVS

About SAP SE

Founded in 1972 by former IBM employees, SAP provides database technology and enterprise resource planning software to enterprises around the world. Across more than 180 countries, the company serves 440,000 customers, approximately 80% of which are small to medium-size enterprises.

Read more on SAP